Clinical Trial Update: Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Argatroban for preventing occlusion and restenosis after intracranial and extracranial artery stenting; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Cerebrovascular Disease

Drugs mentioned

• Argatroban (argatroban)

Snippet

Sponsor: Jinling Hospital, China | Conditions: CVD | Phase 4 | Status: COMPLETED | Results posted: 2014-11-07